Tumor suppressor activity of the human consensus type I interferon gene

Area of Science:

• Molecular Biology
• Cancer Research
• Immunology

Background:

• Type I interferons (IFN) possess known antiproliferative and potential tumor suppressor activities.
• Myelogenous leukemic K562 cells are deficient in type I IFN, representing a model for studying IFN's effects.
• The oncogenic potential of K562 cells necessitates understanding mechanisms to counteract tumor development.

Purpose of the Study:

• To investigate the tumor suppressor activity of a synthetic human consensus type I interferon gene (IFN-con1).
• To assess the effects of constitutive IFN-con1 expression on the malignant phenotype of K562 cells in vitro and in vivo.
• To explore the impact of IFN-con1 on cell proliferation, differentiation, and apoptosis.

Main Methods:

• Construction of eukaryotic vectors with the IFN-con1 gene under various promoters (CMV, MT, RSV LTR).
• Stable transfection of K562 cells with these vectors.
• Evaluation of tumor growth in nude mice and in vitro assays (colony formation, cell cycle analysis, apoptosis assays).

Main Results:

• Constitutive IFN-con1 expression reverted the malignant phenotype of K562 cells, leading to loss of tumorigenicity in vivo.
• Co-administration of IFN-con1 expressing cells with parental tumor cells retarded tumor growth.
• In vitro, IFN-con1 reduced cell growth, colony formation, induced S-phase arrest, and promoted apoptosis.
• IFN-con1 expression also elevated erythroid differentiation.

Conclusions:

• An active IFN-con1 gene effectively counteracts the oncogenic potential of K562 cells.
• IFN-con1 acts as a tumor suppressor by modulating cell proliferation, differentiation, and programmed cell death.
• The findings support the therapeutic potential of type I interferons in cancer treatment.